PHM-Exch> Big Pharma CEOs Rake in $1.57 Billion in Pay

Claudio Schuftan cschuftan at phmovement.org
Fri May 10 02:23:08 PDT 2013


From: shila kaur <kaur_shila at yahoo.com>

courtesy  of Dr Ken Harvey.
http://www.huffingtonpost.com/ethan-rome/big-pharma-ceo-pay_b_3236641.html

Posted: 05/08/2013 8:19 am | Ethan Rome

For people who were blown away to learn recently that the 11 largest global
pharmaceutical companies made an astonishing $711 billion in profits over
the last decade, here's another measure of the industry's greed: the same
companies paid their chief executive officers a combined$1.57 billion in
that period. Not bad work if you can get it. They achieved this thanks in
part to their systematic exploitation of Medicare and an epidemic of
illegal marketing activity.

According to corporate filings analyzed by Health Care for America Now
(HCAN), in 2012 the drug companies' CEOs drew total compensation of $199.2
million, two and a half times the total in 2003. In 2006, the first year of
the Medicare prescription drug law, the pay of the CEOs jumped by $58.9
million from the previous year, the largest one-year increase in the decade
HCAN reviewed.

Inflated Drug Prices

These huge spikes in pay coincided with eye-popping profits bolstered by a
provision the pharmaceutical lobby inserted into the law to prohibit
Medicare from using its unparalleled purchasing power to obtain discounts
or negotiate prices with drug companies. By prohibiting Medicare to get
better drug prices, the federal government is effectively subsidizing the
greed of the drug makers and their CEOs. As a result, Americans pay vastly
higher prices than people in other countries for identical drugs. This is
ludicrous and wasteful. It hurts the government, seniors and middle-class
families.

It should not be the official policy of the United States to price-gouge
our people and government - a practice that's especially offensive at a
time when some in Washington are talking about cutting Medicare benefits.
Simply empowering Medicare to buy drugs under the same bulk purchasing
discounts used by state Medicaid programs would save the federal government
billions. For example, the Medicare Drug Savings Act, introduced by Sen.
Jay Rockefeller (D-WV), would save $141 billion over the next 10 years
without reducing Medicare benefits. Similar measures are in President
Obama's budget proposal and the House Democratic budget plan.

Illegal and Improper Conduct on the Rise

The increases in CEO pay and drug company profits also corresponded with a
surge in illegal and improper conduct by the industry. From 2003 to 2012,
financial penalties paid by drug manufacturers to settle allegations of
illegal marketing, price-gouging of government programs and other
violations rose by more than 500 percent, according to a report issued by
Public Citizen in September 2012.
In 2003, there were only nine settlements with the federal or state
governments, amounting to $967 million in penalties. In 2011, federal and
state government agencies reached a record 44 settlement agreements with
drug makers. And by July 2012, with the year only half over, drug companies
had already agreed to pay nearly $6.6 billion as part of 19 settlements
with the government. Data on the second half of 2012 have not yet been
compiled by Public Citizen.

Here's the kicker: The most common drug-company violation cited by
regulators and law enforcement agencies between 1991 and July 2012 was
overcharging government health programs. Really? How much overcharging do
they need?

Over the last decade, the drug companies racked up unprecedented penalties
for criminal and civil violations. They jacked up prices for seniors and
the government. They made excessive profits and gave unconscionable
compensation to the CEOs in charge of this all.

End Corporate Tax Giveaways

It is obscene that any lawmakers in Washington -- even the most extremist
Republicans who hate civilization as we know it -- are even talking about
cutting benefits for seniors in the midst of what amounts to a drug
industry scandal.

We shouldn't be making any benefit cuts to Medicare, Medicaid, the
Affordable Care Act or Social Security. Not now, not ever. Instead, we
should make the wealthiest Americans pay their fair share in taxes and
eliminate indefensible special-interest tax breaks and subsidies for big
corporations like the companies that ship jobs overseas, Big Oil, and a
drug industry that has made a science out of ripping off the American
people.

* * * * *
HCAN's analysis of CEO pay focused on 11 companies: Johnson & Johnson,
Abbott Laboratories, Pfizer, Novartis, Eli Lilly, Roche, Merck,
Bristol-Myers Squibb, Sanofi, GlaxoSmithKline and AstraZeneca. Over the
10-year period, the $1.57 billion in total compensation was split among 27
executives. The top earners in 2012 were Johnson & Johnson's William
Weldon, who took in $29.8 million, and Pfizer's Ian Read, who received
$25.6 million. By comparison, the median household income in the U.S. last
year was $50,054, while half of all Medicare beneficiaries had less than
$22,500 in annual income.

Click below for details on Big Pharma's annual CEO compensation
expenditures.

http://healthcareforamericanow.org/wp-content/uploads/2013/05/ceo-earnings-table-2013-0507-for-web.pdf


In April, HCAN compiled data showing that the 11 drug companies
reported$711.4 billion in profits over the same 10-year span.


Instructions

View the post in context, access attachments or reply:
http://www.healthyskepticism.org/global/forums/viewthread/348/
or reply to pyrrho at healthyskepticism.org who will prompt Peter Mansfield to
submit your reply for you.

Start a new thread or browse the forums:
http://www.healthyskepticism.org/global/forums
then choose a category.

Information about the forums and email notification options:
http://www.healthyskepticism.org/global/groups/info/hs-members
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20130510/36bf6263/attachment.html>


More information about the PHM-Exchange mailing list